| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| xl880 | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stomach[MeSHID:D013270] Adenocarcinoma[MeSHID:D000230] Malignant Neoplasms[MeSHID:D009369] Cells[MeSHID:D002477] Renal Cell Carcinoma[MeSHID:D002292] Malignant neoplasm of breast[MeSHID:D001943] |
0.23 | phase 2 | unknown |
| xl880 | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stomach[MeSHID:D013270] Adenocarcinoma[MeSHID:D000230] Malignant Neoplasms[MeSHID:D009369] Cells[MeSHID:D002477] Renal Cell Carcinoma[MeSHID:D002292] Malignant neoplasm of breast[MeSHID:D001943] |
0.54 | phase 2 | unknown |
| click here to return to the previous page | ||||||||